American Lung Association Launches PPF Awareness Campaign on World ILD Day

  • American Lung Association launched a national campaign on September 16, 2026, to raise awareness of progressive pulmonary fibrosis (PPF) on World Interstitial Lung Disease Day.
  • The campaign includes educational resources, one-on-one support, and free access to the Lung Health Navigator program.
  • PPF is characterized by worsening lung scarring, leading to reduced lung function and difficulty breathing.
  • Early warning signs of PPF include worsening shortness of breath, unusual fatigue, and weight loss without trying.
  • The campaign is supported by Boehringer Ingelheim.

The American Lung Association's campaign addresses a critical gap in awareness and early intervention for progressive pulmonary fibrosis, a condition affecting a subset of interstitial lung disease patients. With over 200 types of ILD, the initiative underscores the need for specialized care and timely diagnosis. The campaign's focus on education and support aligns with broader trends in patient-centered healthcare, emphasizing the importance of early intervention in managing chronic diseases.

Patient Engagement
How the campaign's educational resources and Lung Health Navigator program will impact early diagnosis and treatment of PPF.
Partnership Dynamics
Whether Boehringer Ingelheim's support will lead to further collaborations in lung disease awareness and treatment.
Outreach Effectiveness
The pace at which the campaign can close the education gap for ILD patients and caregivers.